Advertisement

Topics

OncBioMune to investigate new prostate cancer drug in Phase II trial

19:00 EDT 3 Sep 2017 | Net Resources International

OncBioMune Pharmaceuticals has reported an ongoing review of its Phase II clinical trial protocol by the regulatory committee at Beth Israel Deaconess Medical Centre / Harvard Medical School in the US for evaluation of ProscaVax to treat early stage …

Original Article: OncBioMune to investigate new prostate cancer drug in Phase II trial

NEXT ARTICLE

More From BioPortfolio on "OncBioMune to investigate new prostate cancer drug in Phase II trial"

Quick Search
Advertisement
 

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...